Once a week.
Subscribe to our weekly newsletter.
Do antidepressants create more mental illness than they cure?
Robert Whitaker discusses the long-term impact of prescription medication.
- Many antidepressants show no better efficacy than placebo or talk therapy in long-term usage.
- Proselytizing pharmaceutical interventions has been part of a concerted effort since the 1970s.
- Journalist Robert Whitaker discusses the impact of pathologizing children, moral therapy, and more.
Doctors wrote a record number of prescriptions for Zoloft in March, causing the FDA to add this SSRI to its drug shortage list. Zoloft prescriptions then dropped in April—4.5 million, down from 4.9 million—yet these numbers represent a startling upward trend in antidepressant usage. Nearly 13 percent of the US population over age 12 now regularly swallow these pills.
Why would a 12-year-old need an antidepressant? Robert Whitaker, author of "Mad in America" and Anatomy of An Epidemic," discusses the pathologizing of children during our recent conversation. Whitaker has won a number of awards for his reporting on the psychiatry industry; he was a Pulitzer finalist for a series on psychiatric research he co-wrote for the Boston Globe. While his investigative reporting covers a range of topics, an important thread weaves together his work: Why do Americans take so many prescription drugs?
In"Anatomy of an Epidemic," Whitaker points out that as prescriptions for SSRIs, SNRIs, and antipsychotics rise, so do anxiety and depression diagnoses. If these drugs worked, fewer people should be diagnosed. In a for-profit health care system, however, new customers are always needed. Minor complaints are now pathologized. Creating an illness is the best way to sell a drug.
The 20th century represented a remarkable turning point in medicine. It also marked the beginning of a tragic misunderstanding of mental health. After millions of years of successful evolution, humans were suddenly victims to brain chemistry gone awry. We were sold on the idea that chemical imbalances are the cause of anxiety and depression, not a biological effect created by environmental conditions. Antidepressants predominantly treat a symptom, not the cause, of our malaise.
As Whitaker mentions, short-term use of antidepressants can be helpful. Even with an increasing number of studies detailing the negative long-term effects of these drugs, we're swallowing more pills than ever. I chatted with Robert about why that is and how we can course correct. Our talk was edited for clarity, but you can watch the full conversation or read the transcript below.
EarthRise 91: Do antidepressants create more mental illness than they cure? (with Robert Whitaker)
Derek: Why did you begin investigating the medicalization of psychiatry?
Bob: I co-wrote a series for The Boston Globe on abuses of psychiatric patients in research settings. While I was doing that research, I came upon two World Health Organization studies on outcomes for schizophrenia patients. They were cross-cultural studies in nine different nations, and both times they found outcomes were much better in poor countries than "developing" countries. India, Colombia, and Nigeria fared better than the US and other rich countries. The World Health Organization actually concluded that living in a developed country is a strong predictor you'll have a bad outcome if you're diagnosed with schizophrenia. I wondered why living in a developed country, with all of our advances in medicine, would be a predictor of a bad outcome.
The common narrative was how we were making progress in treating mental disorders. We were finding that they were due to chemical imbalances; we had drugs to fix those chemical imbalances. Yet here were cross-cultural studies finding something much different.
I also found that they use antipsychotics very differently: for short-term but not long-term. That also went against what I knew to be true.
The final thing that launched me into this was looking at a Harvard study that found outcomes for schizophrenia patients in the US had declined in the last 30 years; they're no better than they'd been in the first third of the 20th century. That also belied the narrative of progress.
D: I was prescribed Xanax for a short period of time when I suffered from severe panic disorder. When I explained to my doctor what was happening, she immediately said, "What you're going through is no different than any physical disease." When I read "Anatomy of an Epidemic," it struck me how this exact message had been marketed as the proper approach for treating mental health in the early fifties. Writing of that era, you discuss the American Medical Association, pharmaceutical industry, and government working together to drive that narrative.
B: I love science. It's one of the most beautiful manifestations of the human mind. What I gradually came to understand is that we weren't seeing the presence of a scientific mind in this creation of the narrative of a chemical imbalance.
Guild interests were at play. You said you were told that "this is like any other physical disease." The reason that works so well for a commercial narrative is because I can't get a drug approved for "anxiety of life" or "general unhappiness." But I can get a drug for panic disorder. I can get approved for something seen as a biological condition.
From a pharmaceutical point of view, if you can create a narrative that the discomfort of life is a biological condition, you're going to expand your market dramatically. Before 1980—which is when panic disorder was first identified as a specific disorder—the group of things that were seen as biological was pretty small. It was going to be hard for the pharmaceutical market to expand beyond that.
Why did psychiatry want to tell this tale? Psychiatry in the fifties and sixties had a lot of Freudian impulses and psychodynamic thinking. Then in the seventies, you see a guild whose survival as a medical discipline was under attack. As the benzodiazepines were popping up—those were the first real popular psychiatric drugs—there were problems with addiction, withdrawal, and lack of efficacy over time.
In the seventies, the American Psychiatric Association as a guild felt threatened. Diagnoses were being challenged. It was in competition with talk therapy counseling and other ways of approaching wellness. You can see them saying, "How can we rise above this competitive fray?"
Well, what image has power in American society? The white coat. They said, "We need to put on the white coat. If we call these diseases of the brain, we're now in that field of (almost) infectious disease medicine." You start telling yourself a story and you're going to want to believe that story. You can see psychiatry trying to convince itself that these diseases are chemical imbalances.
A worker at Galenika, a major Serbian pharmaceutical company, stacks on October 23, 2009 packages of Bensedin anti-depressant pills. "A Benjo a day takes your troubles away," said a tongue-in-cheek Belgrade graffiti featuring the slang name of the popular antidepressant in the 1990s.
Photo: AFP via Getty Image
D: A recent analysis showed that trials for esketamine were rushed and did not show true efficacy, but the FDA approved the drug anyway. This is the first psychedelic approved for medical use, yet we seem to be making the same mistakes as with other drugs. How do we break this loop?
B: When a pharmaceutical company wants to get a drug approved, they're going to design the study in ways that make their drug look good. There are all sorts of tricks. If you know of certain side effects, don't put them on the checklist of problems that you look for and you won't get nearly as many spontaneously reported actions. People who are funding the studies of these drugs by and large have a vested interest in seeing them approved.
Our mechanism of approval is also misunderstood. People generally think that if a drug is approved by the FDA, that means it's safe and good for you. The FDA isn't actually saying that the benefits outweigh the harms. It's saying we have this standard for approving a drug: if you can show two trials where it has statistically significant benefit over placebo, that's a sign of efficacy.
Let's say you have a drug that provides a relief of symptoms in 20 percent of people. In placebo it's 10 percent. How many people in that study do not benefit from the drug? Nine out of 10. How many people are exposed to the adverse effects of the drug? 100 percent.
They'll pass that drug because it meets this small standard of benefit over placebo. And they're not subtracting the risk; they're just warning of the risk. It's not up to doctors to decide whether it's helpful. This process is just saying, "it's met our societal standard for getting it on the market."
We also don't measure long-term exposure. If you look at Xanax, it doesn't show any efficacy after about four weeks. If you're taking it on a daily basis, you really should get off it. But all sorts of people have been on it for two years, three years, five years, 10 years. We don't have a mechanism for assessing what happens to people on these drugs for that amount of time.
D: Why does the medical industry not discuss the power of placebo more often?
B: This goes to a larger question about how we think about wellness as a society. There have been a lot of changes in medicine, but the benefits of antibiotics created a mindset about how effective drugs could be for whatever ails you. It set in motion this idea that medicine could come forth with pills that could help whatever you might be presenting with. You see this rapid rise in the use of prescriptions as well.
Increasingly, doctors found themselves in a position where patients were hoping to leave with a prescription. You can't write a prescription for placebo. It would probably be very helpful if you could. The interaction between doctor and patient is actually a sort of placebo interaction. The patient comes for help, they think the doctor has magical potions, and they want to leave with that magical potion. That's in our mindset.
Original building of The Retreat, York. Instituted 1792.
Photo: Wikimedia Commons
D: One of the most powerful stories in "Anatomy of an Epidemic" is the 19th century Quaker practice of moral therapy. Can you foresee a return to this sort of model?
B: I love the humility in it. They admitted they didn't really know what causes madness, but here's the key: they said, "we know they're brethren. They're humans, like all of us." Then they asked, "What do we like? We all like a comforting environment; we need shelter; we need food; it's good to have interests; it's good to have socialization and respect toward each other."
One of the beautiful aspects of moral therapy is they wanted to create these residences out in the country. They thought nature could be very healing, diet could be very healing, a little glass of port at four in the afternoon could be healing.
My favorite part of the moral therapy approach was they would hold a mirror to reflect the image back not of a bad person, but the image of someone who could be in society, who could be with others without fear. They were creating environments where people felt safe and found meaning. They felt respected as well.
If you look at the medical notes, these people were psychotic. They were having trouble assessing reality. Historians found that with this sort of comforting environment many people, about two-thirds, their psychosis would abate naturally over time. Most would never come back to the hospital; they would have a time of psychosis rather than a chronic illness.
Our drug basis is very different: We're going to fix something wrong with the inside of your head. Moral therapy is about fixing the environment you move through and creating a new environment. Our mental health arises within environments, not just the inside of your head.
D: I walked a half-mile to school at age six, so I come from quite a different time, even though I'm only 44. If I was growing up now, I would be put on a drug for ADHD, as I was pretty hyper. Yet our prefrontal cortex doesn't fully develop until our twenties. The idea of putting six-year-olds on these drugs is insane.
B: This is one of the biggest moral questions of our time: How do we raise our children? The biggest moral question of our time is climate change. If we don't respond to that, we're really screwing future generations. But it is a big question.
We've created a pathologizing environment for them. Why did we do that?
If you go back to the early nineties, the drug companies recognized the adult market for SSRIs was being saturated. Where's the untapped market? Kids.
You had already started to see that with stimulants for ADHD, but what you see post-1980 is market forces: pharmaceutical companies worked with academic psychiatry to start talking about all of these childhood disorders and the need to medicate them.
What I find particularly distressing is that all the data you can find on medicating kids is ultimately negative, even on symptoms, cognitive function, social functioning, and academic achievement. Most frightening of all—since you opened this with ideas of frontal lobe development—all of our animal studies show that these drugs affect brain development.
If you look at the harm done from pathologizing childhood, it's so broad-based. Kids are taught to monitor their own self. If they find themselves sad, that's wrong, that's abnormal. Whereas in the past, you might think, "I'm sad today." You're expected to be happy, and if you're not happy, that's a problem. We've created a situation where kids are primed to think, "something's wrong with me," and parents are primed to think, "something's wrong with my kid."
Going back to moral therapy: Do we ask about the spaces kids inhabit today? You got to walk a half-mile to school. How many kids get to walk to school today? How many kids feel pressure by second grade to start getting good grades because they have to worry about getting into college?
You create a narrative that helps drive people into this "abnormal" category, so they start using these drugs. And we have all this evidence that it isn't benefiting kids.
We've seen rising suicide rates in kids. Then there's the rise in antidepressants, too. Go to college campuses today, the percentage of kids that arrive with a diagnosis and a prescription is 25 to 30 percent. Do you really think 30 percent of our kids are mentally ill?
You've given kids messages that they're abnormal, ill, and compromised, instead of giving them messages of resilience, of how to grow into life. You can't chase happiness. You can chase meaning in life. You can chase doing things that have some meaning to the social good. I can't just try to be happy. Happy visits you when you're engaged in social relationships, meaning, community, that sort of thing.
The pathologizing of kids is taking away the right of every child to become the author of their own life: to make choices, to try things out, to decide what they want to be, and to grapple with their own minds.
Inventions with revolutionary potential made by a mysterious aerospace engineer for the U.S. Navy come to light.
- U.S. Navy holds patents for enigmatic inventions by aerospace engineer Dr. Salvatore Pais.
- Pais came up with technology that can "engineer" reality, devising an ultrafast craft, a fusion reactor, and more.
- While mostly theoretical at this point, the inventions could transform energy, space, and military sectors.
The U.S. Navy controls patents for some futuristic and outlandish technologies, some of which, dubbed "the UFO patents," came to light recently. Of particular note are inventions by the somewhat mysterious Dr. Salvatore Cezar Pais, whose tech claims to be able to "engineer reality." His slate of highly-ambitious, borderline sci-fi designs meant for use by the U.S. government range from gravitational wave generators and compact fusion reactors to next-gen hybrid aerospace-underwater crafts with revolutionary propulsion systems, and beyond.
Of course, the existence of patents does not mean these technologies have actually been created, but there is evidence that some demonstrations of operability have been successfully carried out. As investigated and reported by The War Zone, a possible reason why some of the patents may have been taken on by the Navy is that the Chinese military may also be developing similar advanced gadgets.
Among Dr. Pais's patents are designs, approved in 2018, for an aerospace-underwater craft of incredible speed and maneuverability. This cone-shaped vehicle can potentially fly just as well anywhere it may be, whether air, water or space, without leaving any heat signatures. It can achieve this by creating a quantum vacuum around itself with a very dense polarized energy field. This vacuum would allow it to repel any molecule the craft comes in contact with, no matter the medium. Manipulating "quantum field fluctuations in the local vacuum energy state," would help reduce the craft's inertia. The polarized vacuum would dramatically decrease any elemental resistance and lead to "extreme speeds," claims the paper.
Not only that, if the vacuum-creating technology can be engineered, we'd also be able to "engineer the fabric of our reality at the most fundamental level," states the patent. This would lead to major advancements in aerospace propulsion and generating power. Not to mention other reality-changing outcomes that come to mind.
Among Pais's other patents are inventions that stem from similar thinking, outlining pieces of technology necessary to make his creations come to fruition. His paper presented in 2019, titled "Room Temperature Superconducting System for Use on a Hybrid Aerospace Undersea Craft," proposes a system that can achieve superconductivity at room temperatures. This would become "a highly disruptive technology, capable of a total paradigm change in Science and Technology," conveys Pais.
High frequency gravitational wave generator.
Credit: Dr. Salvatore Pais
Another invention devised by Pais is an electromagnetic field generator that could generate "an impenetrable defensive shield to sea and land as well as space-based military and civilian assets." This shield could protect from threats like anti-ship ballistic missiles, cruise missiles that evade radar, coronal mass ejections, military satellites, and even asteroids.
Dr. Pais's ideas center around the phenomenon he dubbed "The Pais Effect". He referred to it in his writings as the "controlled motion of electrically charged matter (from solid to plasma) via accelerated spin and/or accelerated vibration under rapid (yet smooth) acceleration-deceleration-acceleration transients." In less jargon-heavy terms, Pais claims to have figured out how to spin electromagnetic fields in order to contain a fusion reaction – an accomplishment that would lead to a tremendous change in power consumption and an abundance of energy.
According to his bio in a recently published paper on a new Plasma Compression Fusion Device, which could transform energy production, Dr. Pais is a mechanical and aerospace engineer working at the Naval Air Warfare Center Aircraft Division (NAWCAD), which is headquartered in Patuxent River, Maryland. Holding a Ph.D. from Case Western Reserve University in Cleveland, Ohio, Pais was a NASA Research Fellow and worked with Northrop Grumman Aerospace Systems. His current Department of Defense work involves his "advanced knowledge of theory, analysis, and modern experimental and computational methods in aerodynamics, along with an understanding of air-vehicle and missile design, especially in the domain of hypersonic power plant and vehicle design." He also has expert knowledge of electrooptics, emerging quantum technologies (laser power generation in particular), high-energy electromagnetic field generation, and the "breakthrough field of room temperature superconductivity, as related to advanced field propulsion."
Suffice it to say, with such a list of research credentials that would make Nikola Tesla proud, Dr. Pais seems well-positioned to carry out groundbreaking work.
A craft using an inertial mass reduction device.
Credit: Salvatore Pais
The patents won't necessarily lead to these technologies ever seeing the light of day. The research has its share of detractors and nonbelievers among other scientists, who think the amount of energy required for the fields described by Pais and his ideas on electromagnetic propulsions are well beyond the scope of current tech and are nearly impossible. Yet investigators at The War Zone found comments from Navy officials that indicate the inventions are being looked at seriously enough, and some tests are taking place.
If you'd like to read through Pais's patents yourself, check them out here.
Laser Augmented Turbojet Propulsion System
Credit: Dr. Salvatore Pais
People tend to reflexively assume that fun events – like vacations – will go by really quickly.
For many people, summer vacation can't come soon enough – especially for the half of Americans who canceled their summer plans last year due to the pandemic.
But when a vacation approaches, do you ever get the feeling that it's almost over before it starts?
If so, you're not alone.
In some recent studies Gabriela Tonietto, Sam Maglio, Eric VanEpps and I conducted, we found that about half of the people we surveyed indicated that their upcoming weekend trip felt like it would end as soon as it started.
This feeling can have a ripple effect. It can change the way trips are planned – you might, for example, be less likely to schedule extra activities. At the same time, you might be more likely to splurge on an expensive dinner because you want to make the best of the little time you think you have.
Where does this tendency come from? And can it be avoided?
Not all events are created equal
When people look forward to something, they usually want it to happen as soon as possible and last as long as possible.
We first explored the effect of this attitude in the context of Thanksgiving.
We chose Thanksgiving because almost everyone in the U.S. celebrates it, but not everyone looks forward to it. Some people love the annual family get-together. Others – whether it's the stress of cooking, the tedium of cleaning or the anxiety of dealing with family drama – dread it.
So on the Monday before Thanksgiving in 2019, we surveyed 510 people online and asked them to tell us whether they were looking forward to the holiday. Then we asked them how far away it seemed, and how long they felt it would last. We had them move a 100-point slider – 0 meaning very short and 100 meaning very long – to a location that reflected their feelings.
As we suspected, the more participants looked forward to their Thanksgiving festivities, the farther away it seemed and shorter it felt. Ironically, longing for something seems to shrink its duration in the mind's eye.
Winding the mind's clock
Most people believe the idiom “time flies when you're having fun," and research has, indeed, shown that when time seems to pass by quickly, people assume the task must have been engaging and enjoyable.
We reasoned that people might be over-applying their assumption about the relationship between time and fun when judging the duration of events yet to happen.
As a result, people tend to reflexively assume that fun events – like vacations – will go by really quickly. Meanwhile, pining for something can make the time leading up to the event seem to drag. The combination of its beginning pushed farther away in their minds – with its end pulled closer – resulted in our participants' anticipating that something they looked forward would feel as if it had almost no duration at all.
In another study, we asked participants to imagine going on a weekend trip that they either expected to be fun or terrible. We then asked them how far away the start and end of this trip felt like using a similar 0 to 100 scale. 46% of participants evaluated the positive weekend as feeling like it had no duration at all: They marked the beginning and the end of the vacation virtually at the same location when using the slider scale.
Thinking in hours and days
Our goal was to show how these two judgments of an event – the fact that it simultaneously seems farther away and is assumed to last for less time – can nearly eliminate the event's duration in the mind's eye.
We reasoned that if we didn't explicitly highlight these two separate pieces – and instead directly asked them about the duration of the event – a smaller portion of people would indicate virtually no duration for something they looked forward to.
We tested this theory in another study, in which we told participants that they would watch two five-minute-long videos back-to-back. We described the second video as either humorous or boring, and then asked them how long they thought each video would feel like it lasted.
We found that the participants predicted that the funny video would still feel shorter and was farther away than the boring one. But we also found that participants believed it would last a bit longer than the responses we received in the earlier studies.
This finding gives us a way to overcome this biased perception: focus on the actual duration. Because in this study, participants directly reported how long the funny video would last – and not the perceived distance of its beginning and its end – they were far less likely to assume it would be over just as it started.
While it sounds trivial and obvious, we often rely on our subjective feelings – not objective measures of time – when deciding how long a period of time will feel and how to best use it.
So when looking forward to much-anticipated events like vacations, it's important to remind yourself just how many days it will last.
You'll get more out of the experience – and, hopefully, put yourself in a better position to take advantage of the time you do have.
A global survey shows the majority of countries favor Android over iPhone.
- When Android was launched soon after Apple's own iPhone, Steve Jobs threatened to "destroy" it.
- Ever since, and across the world, the rivalry between both systems has animated users.
- Now the results are in: worldwide, consumers clearly prefer one side — and it's not Steve Jobs'.
A woman on her phone in Havana, Cuba. Mobile phones have become ubiquitous the world over — and so has the divide between Android and iPhone users.Credit: Yamil Lage / AFP via Getty Images.
Us versus them: it's the archetypal binary. It makes the world understandable by dividing it into two competing halves: labor against capital, West against East, men against women.
These maps are the first to show the dividing lines between one of the world's more recent binaries: Android vs. Apple. Published by Electronics Hub, they are based on a qualitative analysis of almost 350,000 tweets worldwide that presented positive, neutral, and negative attitudes toward Android and/or Apple.
Steve Jobs wanted to go "thermonuclear"
Feelings between Android and Apple were pretty tribal from the get-go. It was Steve Jobs himself who said, when Google rolled out Android a mere ten months after Apple launched the iPhone, "I'm going to destroy Android, because it's a stolen product. I'm willing to go thermonuclear war on this."
Buying a phone is like picking a side in the eternal feud between the Hatfields and the McCoys. Each choice for automatically comes with an in-built arsenal of arguments against.
If you are an iPhone person, you appreciate the sleekness and simplicity of its design, and you are horrified by the confusing mess that is the Android operating system. If you are an Android aficionado, you pity the iPhone user, a captive of an overly expensive closed ecosystem, designed to extract money from its users.
Even without resorting to those extremes, many of us will recognize which side of the dividing line that we are on. Like the American Civil War, that line runs through families and groups of friends, but that would be a bit confusing to chart geographically. To un-muddle the information, these maps zoom out to state and country level.
If the contest is based on the number of countries, Android wins. In all, 74 of the 142 countries surveyed prefer Android (in green on the map). Only 65 favor Apple (colored grey). That's a 52/48 split, which may not sound like a decisive vote, but it was good enough for Boris Johnson to get Brexit done (after he got breakfast done, of course).
And yes, math-heads: 74 plus 65 is three short of 142. Belarus, Fiji, and Peru (in yellow on the map) could not decide which side to support in the Global Phone War.
What about the United States, home of both the Android and the iPhone? Another victory for the former, albeit a slightly narrower one: 30.16 percent of the tweets about Android were positive versus just 29.03 percent of the ones about Apple.
United States: Texas surrounded!
Credit: Electronics Hub
There can be only one winner per state, though, and that leads to this preponderance of Android logos. Frankly, it's a relief to see a map showing a visceral divide within the United States that is not the coasts versus the heartland.
- Apple dominates in 19 states: a solid Midwestern bloc, another of states surrounding Texas, the Dakotas and California, plus North Carolina, New Hampshire, and Rhode Island.
- And that's it. The other 32 are the United States of Android. You can drive from Seattle to Miami without straying into iPhone territory. But no stopovers in Dallas or Houston – both are behind enemy lines!
North America: strongly leaning toward Android
Credit: Electronics Hub
Only eight of North America's 21 countries surveyed fall into the Apple category.
- The U.S. and Canada lean Android, while Mexico goes for the iPhone.
- Central America is divided, but here too Android wins hands down, 5-2.
Europe: Big Five divided
Credit: Electronics Hub
In Europe, Apple wins, with 20 countries preferring the iPhone, 17 going for Android, and Belarus sitting on the fence.
- Of Western Europe's Big Five markets, three (UK, Germany, Spain) are pro-Android, and two (France, Italy) are pro-Apple.
- Czechia and Slovakia are an Apple island in the Android sea that is Central Europe. Glad to see there is still something the divorcees can agree on.
South America: almost even
Credit: Electronics Hub
In South America, the divide is almost even.
- Five countries prefer Android, four Apple, and one is undecided.
- In Peru, both Android- and Apple-related tweets were 25 percent positive.
Africa: watch out for Huawei
Credit: Electronics Hub
In Africa, Android wins by 17 countries versus Apple's 15.
- There's a solid Android bloc running from South Africa via DR Congo all the way to Ethiopia.
- iPhone countries are scattered throughout the north (Algeria), west (Guinea), east (Somalia), and south (Namibia).
Huawei — increasingly popular across the continent — could soon dramatically change the picture in Africa. Currently still running on Android, the Chinese phone manufacturer has just launched its own operating system, called Harmony.
Middle East: Iran vs. Saudi Arabia (again)
Credit: Electronics Hub
In the Middle East and Central Asia, Android wins 8 countries to Apple's 6.
- But it's complicated. One Turkish tweeter wondered how it is that iPhones seem more popular in the Asian half of Istanbul, while Android phones prevailed in the European part of the city.
- The phone divide matches up with the region's main geopolitical one: Iran prefers Android, Saudi Arabia the iPhone.
Asia-Pacific: Apple on the periphery
Credit: Electronics Hub
Another wafer-thin majority for Android in the Asia-Pacific region: 13 countries versus 12 for Apple — and one abstention (Fiji).
- The two giants of the Asian mainland, India and China, are both Android countries. Apple countries are on the periphery.
- And if India is Android, its rival Pakistan must be Apple. Same with North and South Korea.
Experts point to the fact that both operating systems are becoming more alike with every new generation as a potential resolution to the conflict. But as any student of human behavior will confirm: smaller differences will only exacerbate the rivalry between both camps.
Maps taken from Electronics Hub, reproduced with kind permission.
Strange Maps #1096
Got a strange map? Let me know at email@example.com.
English is a dynamic language, and this summer's new additions to dictionary.com tell us a lot about how we're living.